• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: Sudocrem     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:Substance100020090, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)

Type: Thingcompanyschema:Organizationdul:Agentdul:SocialPersonagentwikidata:Q24229398OrganizationBusiness enterpriseyago:WikicatOintmentsyago:Agent114778436yago:CausalAgent100007347yago:Drug103247620yago:Matter100020827yago:Medicine103740161yago:Ointment103845550yago:PhysicalEntity100001930yago:Remedy104074482Foodorganisationyago:Substance100020090 New Facet based on Instances of this Class

Sudocrem (/ˈsudəkrɛm/ or /ˈsudəkrim/ in Ireland) is an over-the-counter medicated cream aimed primarily at the treatment of nappy rash. It contains a water-repellent base (consisting of oils/waxes); protective and emollient agents; antibacterial and antifungal agents; and a weak anesthetic. As well as nappy rash, it can also be used to treat eczema, bedsores, minor burns, surface wounds, sunburn and chilblains. It was manufactured by pharmaceutical company Forest Laboratories Europe up until July 2014 when the company was acquired by, and combined with, Actavis plc. On March 17, 2015, Actavis completed the acquisition of Allergan, creating a $23 billion diversified global pharmaceutical company.